nicardipine has been researched along with Arterial Occlusive Diseases in 4 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of two potent vasodilating drugs, captopril (C) (25 mg tid), nicardipine (N) (20 mg tid), and placebo (P) were evaluated and compared, in 10 men (mean age of sixty-five years) with intermittent claudication from moderate to severe multilevel chronic occlusive arterial disease (COAD) of the lower extremity, by use of the Doppler ultrasonic method, at rest and after Carter's exercise test." | 5.06 | Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound. ( Bartoli, P; Bernardi, D; Ferreri, A; Geri, AB; Ieri, A, 1988) |
| "Nicardipine-based treatment is therefore effective, safe, and well tolerated in elderly hypertensive patients with concomitant disease." | 1.28 | The clinical performance of nicardipine in elderly hypertensive patients with concomitant diseases. ( Leonetti, G, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandhu, R | 1 |
| Biro, GP | 1 |
| Kamei, K | 1 |
| Tsuchida, S | 1 |
| Nishikibe, M | 1 |
| Leonetti, G | 1 |
| Bernardi, D | 1 |
| Bartoli, P | 1 |
| Ferreri, A | 1 |
| Geri, AB | 1 |
| Ieri, A | 1 |
1 trial available for nicardipine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound.
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Captopril; Clinical Trials as Topic; Double-Blind | 1988 |
3 other studies available for nicardipine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Changes in the myocardial area at risk, infarct size, and collateral flow following nicardipine infusion in dogs.
Topics: Animals; Arterial Occlusive Diseases; Blood Flow Velocity; Collateral Circulation; Coronary Circulat | 1991 |
[Effects of NB-818 on a transient bilateral common carotid arteries occlusion model in Mongolian gerbils].
Topics: Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Carotid Artery Diseases; Dihydropyri | 1989 |
The clinical performance of nicardipine in elderly hypertensive patients with concomitant diseases.
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Diabetes Complications; Humans; | 1989 |